inhibitor

(redirected from Vasopeptidase Inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
See: deterrent
Mentioned in ?
References in periodicals archive ?
The most promising novel class of products is the Vasopeptidase inhibitors, which will account for over half of the total sales of emerging products in 2006.
Antihypertensive Therapeutic Market Expected to Reach $38.5 billion by 2006
VANLEV, discovered by Bristol-Myers Squibb researchers, is the most clinically developed member of a new class of cardiovascular compounds known as vasopeptidase inhibitors (VPIs).
Bristol-Myers Squibb Seeks Regulatory Approvals Worldwide for Novel Antihypertension Drug VANLEV(TM); New Drug May Prove to Help Millions Of Patients With High Blood Pressure
Omapatrilat is the most clinically advanced member of a class of cardiovascular drugs known as vasopeptidase inhibitors, that simultaneously inhibit neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE), two key enzymes that work together in the cardiovascular system to control heart function and blood pressure.
Clinical Trial Launched to Study Benefits of New Class of Cardiovascular Drugs Versus Current Therapy in Treating Heart Failure

Legal browser ?
Full browser ?